Stand Up To Cancer - standup2cancer.orgThis is where the end of cancer begins
   Please leave this field empty

Press Releases

Share this:

Like this page on Facebook

First SU2C Catalyst RFP Announced with support from Merck

June 21, 2016 - First SU2C Catalyst™ RFP Announced: Exploring New Uses for Keytruda® (pembrolizumab), with Support from Merck

+ More

Stand Up To Cancer Returns For Fifth Live Roadblock Telecast

June 16, 2016 – The Hollywood community is once again uniting to support Stand Up To Cancer (SU2C), a program of the Entertainment Industry Foundation (EIF), which will stage its fifth televised biennial fundraising special on Friday, Sept. 9 (8:00 – 9:00 PM ET/PT / 7:00 PM CT).

+ More

SU2C to Offer Training Modules for Nurses on Front Lines of Administering New Cancer Therapies

May 9, 2016 - In recognition of Nurses Appreciation Week, Stand Up To Cancer (SU2C) announces the development of a series of Certification for Nursing Education (CNE) training modules by experts from Boston College William F. Connell School of Nursing. The CNE modules will equip nurses with the skills and knowledge needed to manage the unique challenges and patient symptoms that accompany administration of emerging immunotherapies to treat cancer.

+ More

Minnie Driver Joins SU2C, OCRFA and NOCC in New PSA

May 5, 2016 – Stand Up To Cancer (SU2C), Ovarian Cancer Research Fund Alliance (OCRFA), and National Ovarian Cancer Coalition (NOCC) have teamed up on a new ovarian cancer public service announcement (PSA) campaign featuring Academy-Award nominated actress Minnie Driver, who lost her grandmother to the disease.

+ More

Stand Up To Cancer and Genentech Join Forces through “Be the Breakthrough” Campaign

May 4, 2016 - Stand Up To Cancer (SU2C) and Genentech announced their latest collaboration “Be the Breakthrough”, a multi-faceted campaign focused on educating Americans on how they can each play a role in the fight against cancer, including screening and participating in clinical trials.

+ More

Innovate Collaborate Accelerate
Cancer accounts for nearly 1 of every 4 deaths in the US.